Stephen Johnston
Royal Marsden NHS Foundation Trust(GB)Royal Marsden Hospital(GB)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies
Most-Cited Works
- → Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer(2009)1,023 cited
- → The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2(2019)960 cited
- → Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer(2016)702 cited
- → MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer(2019)657 cited
- → Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline(2016)635 cited
- → Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial